Top-Thema

13:06 Uhr +2,10%
Deutsche Chemie erwartet auch 2017 keine nennenswerte Dynamik

PTA-PVR : Biofrontera AG: Release according to Article 26, Section 1 of the WpHG

Montag, 28.11.2016 14:05

Voting rights according to article 21-26 WpHG

Leverkusen, Germany (pta029/28.11.2016/14:05) - Release of Voting Rights Announcement according to §§ 21 ff WpHG

Notification of Major Holdings

1. Details of issuer:
Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen, Germany

2. Reason for notification:
Change of Total Voting Rights

3. Details of person subject to the notification obligation
Name: Dr. Christoph Kronabel

4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3


5. Date on which threshold was crossed or reached
21.11.2016

6. Total positions

% of voting rights attached to shares (total of 7.a.) % of voting rights through instruments (total of 7.b.1 + 7.b.2) total of both in % (7.a. + 7.b.) total number of voting rights of issuer
Resulting situation 2.77 0.00 2.77 35,360,763
Previous notification 4,40

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN absolute direct (§ 21 WpHG) absolute indirect (§ 22 WpHG) in % direct (§ 21 WpHG) in % indirect (§ 22 WpHG)
DE0006046113 4,346 976,056 0.01 2.76
Total: 980,402 2.77

b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Voting Rights Absolute Voting Rights in %
Total:

b.2 Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG

Type of instrument Maturity / Expiration Exercise or conversion period Cash or physical transaction Voting Rights Absolute Voting Rights in %
Total:

8. Information in relation to the person subject to the notification obligation

Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity

Name % of voting rights if 3% or higher % of voting rights through instruments if 5% or higher Total of both if 5% or higher
Dr. Christoph Kronabel
Heidelberg Innovation Asset Management GmbH & Co. KG
Heidelberg Innovation BioScience Venture II GmbH & Co. KG i.L.

9. In case of proxy voting according to § 22 Abs. 3 WpHG

Date of general meeting: N/A

10. Other useful information

(end)

emitter: Biofrontera AG
address: Hemmelrather Weg 201, 51377 Leverkusen
country: Germany
contact person: Investor & public relations
phone: +49 (0) 214 87 63 20
e-mail: press@biofrontera.com
website: www.biofrontera.com

ISIN(s): DE0006046113 (share)
stock exchanges: regulated market in Frankfurt, Dusseldorf; free market in Stuttgart, free market in Munich; open market in Berlin, Tradegate

[ source: http://www.pressetext.com/news/20161128029 ]